The clinical applications of high intensity focused ultrasound in the prostate

References

• Cancer Research UK. UK prostate cancer incidence statistics 2002
   Google Scholar
• American Cancer Society. Cancer facts and figures 2005. American Cancer Society, Atlanta, GA 2005
   Google Scholar
• Ahmed S, Lindsey B, Davies J. Emerging minimally invasive techniques for treating localised prostate cancer. BJU Int 2005; 96: 1230–1234
   Google Scholar
• Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Bosch C, Nordling S, Garmo H, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 12;352: 1977–1984
   Google Scholar
• Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BE, Holmberg L. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 12;347: 790–796
   Google Scholar
• Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, et al. 5-year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. J Urol 2005; 173: 1701–1705
   Google Scholar
• Khoo VS. Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy. Clin Oncol (R Coll Radiol) 2005; 17: 560–571
   PubMed Web of Science ®Google Scholar
• Hoznek A, Menard Y, Salomon L, Abbou CC. Update on laparoscopic and robotic radical prostatectomy. Curr Opin Urol 2005; 15: 173–180
   PubMed Web of Science ®Google Scholar
• Gillett MD, Gettman MT, Zincke H, Blute ML. Tissue ablation technologies for localised prostate cancer. Mayo Clin Proc 2004; 79: 1547–1555
   PubMed Web of Science ®Google Scholar
• Kennedy JE. High intensity focused ultrasound in the treatment of solid tumours. Nat Rev: Cancer 2005; 5: 321–327
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Schatzl G, Djavan B, Stulnig T, Marberger M. Long-term outcome of transrectal high- intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol 2000; 37: 687–694
   PubMed Web of Science ®Google Scholar
• American Society for Therapeutic Radiology and Oncology. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37: 1035–1041
   PubMed Web of Science ®Google Scholar
• Uchida T, Illing RO, Cathart PJ, Emberton M. To what extent does PSA Nadir predict subsequent treatment failure following trans-rectal HIFU for presumed localised adenocarcinoma of the prostate?. BJU Int 2006; 98: 537–539
   PubMed Web of Science ®Google Scholar
• Kirkham APS, Hoh I, Illing RO, Freeman A, Emberton M, Allen C. Magnetic Resonance Imaging of the Prostate after High Intensity Focused Ultrasound: Improving treatment and predicting outcome. Radiology 2006; Presented at the Radiology Society of North America (RSNA) November, 2006
   Google Scholar
• Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A. Treatment of localised prostate cancer using high-intensity focused ultrasound. BJU Int 2006; 97: 56–61
   PubMed Web of Science ®Google Scholar
• Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T, et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localised prostate cancer. Int J Urol 2006; 13: 228–233
   Google Scholar
• Illing RO, Leslie TA, Kennedy JE, Calleary JG, Ogden CW, Emberton M. Visually directed HIFU for organ confined prostate cancer–a proposed standard for the conduct of therapy. BJU Int 2006; 98: 1187–1192
   PubMed Web of Science ®Google Scholar
• Blana A, Walter B, Rogenhofer S, Wieland WF. High-intensity focused ultrasound for the treatment of localised prostate cancer: 5-year experience. Urology 2004; 63: 297–300
   PubMed Web of Science ®Google Scholar
• Thuroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A, et al. High-intensity focused ultrasound. J Endourol 2003; 17: 673–677
   PubMed Web of Science ®Google Scholar
• Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004; 71: 29–33
   PubMed Web of Science ®Google Scholar
• Leslie TA. Consensus Meeting of the European Sonablate Usergroup. Personal Communication 2006
   Google Scholar
• Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localised prostate cancer: Feasibility study. J Urol 2004; 171: 2265–2267
   PubMed Web of Science ®Google Scholar
• Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localised prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248–252
   PubMedGoogle Scholar
• Bianco JR, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters. J Urol 2005; 173: 2099–2103
   PubMed Web of Science ®Google Scholar
• D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH. Pre-treatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 2003; 169: 1320–1324
   PubMedGoogle Scholar
• Parker CC, Dearnaley DP. The management of PSA failure after radical radiotherapy for localised prostate cancer. Radiother Oncol 1998; 49: 103–110
   PubMed Web of Science ®Google Scholar
• Amling CL, Lerner SE, Martin SK, Slezak JM, Blute ML, Zinke HORS. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 1999; 161: 857–863
   PubMed Web of Science ®Google Scholar
• Cresswell J, Asterling S, Chaudhuary M, Sheikh N, Greene D. Third-generation cryotherapy for prostate cancer in the UK: A prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006; 97: 969–674
   PubMed Web of Science ®Google Scholar
• Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, et al. Salvage brachytherapy for localised prostate cancer after radiotherapy failure. Urology 1999; 53: 2–10
   Google Scholar
• Gelet A, Chapelon JY, Poissonnier L, Bouvier R, Rouviere O, Curiel L, et al. Local recurrence of prostate cancer after external beam radiotherapy: Early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004; 63: 625–629
   PubMed Web of Science ®Google Scholar
• Murat JF, Poissonier L, Gelet A. Recurrent prostate cancer after radiotherapy - Salvage treatment by high intensity focused ultrasound. Eur Oncol Dis 2006; 1: 64–66
   Google Scholar
• D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localised prostate cancer. JAMA 1998; 280: 969–974
   PubMed Web of Science ®Google Scholar
• Illing RO, Emberton M. The use of trans-rectal high intensity focused ultrasound in salvage treatment for men who have failed primary radiation therapyof presumed organ confined prostate cancer. Presented at the 6th International Symposium on Therapeutic Ultrasound. OxfordUK 2006
   Google Scholar
• de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJA. 11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer. Eur Urol 2003; 44: 32–39
   Google Scholar
• Gelet A. Personal Communication 2005
   Google Scholar
• Chaussy C, Thuroff S, Rebillard X, Gelet A. Technology insight: High-intensity focused ultrasound for urologic cancers. Nat Clin Pract Urol 2005; 2: 191–198
   PubMedGoogle Scholar
• Uchida T, Sanghvi NT, Gardner TA, Koch MO, Ishii D, Minei S, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localised prostate cancer: A preliminary report. Urology 2002; 59: 394–398
   PubMed Web of Science ®Google Scholar
• Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localised prostate cancer. World J Urol 2006; 19: 585–590
   Google Scholar
• Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995; 55: 3346–3351
   PubMed Web of Science ®Google Scholar
• Beerlage HP, Thuroff S, Debruyne FM, Chaussy C, de la Rosette JJ. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localised prostate carcinoma. Urology 1999; 54: 273–277
   PubMed Web of Science ®Google Scholar
• Pasticier G, Ardiet JM, Poissonnier L, Murat JF, Chapelon JY, Gelet A. Salvage radiotherapy after HIFU: Evaluation of tolerance. Presented at the 6th International Symposium on Therapeutic Ultrasound. OxfordUK 2006
   Google Scholar
• Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer. Radiother Oncol 2005; 75: 303–306
   Google Scholar
• Uchida T, Illing RO, Cathart PJ, Emberton M. The effect of neo-adjuvant androgen suppression on prostate cancer related outcomes following HIFU therapy. BJU Int 2006; 98: 770–772
   PubMedGoogle Scholar
• Janoff DM, Peterson C, Mongoue-Tchokote S, Peters L, Beer TM, Wersinger EM, et al. Clinical outcomes of androgen deprivation as the sole therapy for localised and locally advanced prostate cancer. BJU Int 2005; 96: 503–507
   PubMed Web of Science ®Google Scholar
• Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology Jul, 2006; 68: S2–S6
   Google Scholar
• Lucey BC. Radiofrequency Ablation: The Future Is Now. AJR 2006; 186: S237–S240
   Google Scholar
• McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: Problems and possible solutions. Brut Med J MJ 2002; 15;324: 1448–1451
   Google Scholar
• Engineering and Physical Sciences Reasearch Council (EPSRC). Funding Awarded 2006, Report No.: http://gow.epsrc.ac.uk/ViewDepartment.aspx?DepartmentId=2181 and http://gow.epsrc.ac.uk/ViewDepartment.aspx?Department Id=681
   Google Scholar
• Seip R, Chen W, Carlson R, Frizzell LA, Warren G, Smith N, et al. Annular and cylindrical phased array geometries for transrectal high-intensity focused ultrasound (HIFU) using PZT and piezocomposite materials. Proceedings of the 5th International Symposium on Therapeutic Ultrasound. AIP, KyotoJapan 2005
   Google Scholar
• Bercoff J, Pernot M, Tanter M, Fink M. Monitoring thermally-induced lesions with supersonic shear imaging. Ultrason Imaging 2004; 26: 71–84
   PubMed Web of Science ®Google Scholar
• Curiel L, Souchon R, Rouviere O, Gelet A, Chapelon JY. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: Initial comparison with MRI. Ultrasound Med Biol 2005; 31: 1461–1468
   PubMed Web of Science ®Google Scholar
• Miller NR, Bograchev KM, Bamber JC. Ultrasonic temperature imaging for guiding focused ultrasound surgery: Effect of angle between imaging beam and therapy beam. Ultrasound Med Biol 2005; 31: 401–413
   Google Scholar
• Quesson B, de Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 2000; 12: 525–533
   PubMed Web of Science ®Google Scholar
• Yu T, Xiong S, Mason TJ, Wang Z. The use of a micro-bubble agent to enhance rabbit liver destruction using high intensity focused ultrasound. Ultrason Sonochem 2006; 13: 143–149
   Google Scholar
• Mitragotri S. Healing sound: The use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005; 4: 255–260
   Google Scholar
• Burtnyk M, Chopra R, Bronskill M. Simulation of MRI-guided transurethral conformal 3-D ultrasound therapy of the prostate. Presented at the 6th International Symposium on Therapeutic Ultrasound. OxfordUK 2006
   Google Scholar
• Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol 2004; 30: 1217–1222
   PubMed Web of Science ®Google Scholar
• Barqawi A, Crawford ED. Focal therapy in prostate cancer: Future trends. BJU Int 2005; 95: 273–274
   Google Scholar
• Carey BM. Imaging for Prostate Cancer. Clin Oncol (R Coll Radiol) 2005; 17: 553–559
   PubMed Web of Science ®Google Scholar
• Onik G. The male lumpectomy: Rationale for a cancer targeted approach for prostate cryoablation. A review. Technol Cancer Res Treat 2004; 3: 365–370
   PubMed Web of Science ®Google Scholar